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Abstract 
A recently identified gene expression signature of EMT markers containing the transcription 
factor Slug was found present in samples from many publicly available cancer gene 
expression datasets of multiple cancer types except leukemia. We also found many of these 
genes co-expressed in human cancer xenografted cells, but not in mouse stroma cells, 
suggesting that the signature is largely produced by cancer cells undergoing some type of 
EMT.  Here we report that a partial signature consisting of a subset of the co-expressed genes 
of the full signature, including at least Slug (SNAI2), collagens COL1A1, COL1A2, COL3A1, 
COL6A3 and genes DCN and LUM, is also present in leukemia, in which case it is also strongly 
associated with the chemokine CXCL12 (aka SDF1). The same subset of co-expressed genes is 
also strongly present even in normal samples in a tissue-specific manner, with lowest 
expression in brain tissues and highest expression in reproductive system tissues. The full 
signature, with prominent presence of COL11A1, THBS2 and INHBA appears to be triggered in 
solid cancers particularly when cancer cells encounter adipocytes. 
 
Introduction 
A gene expression signature consisting of a set of genes many of which are epithelial-
mesenchymal transition (EMT) markers including the EMT-inducing transcription factor Slug 
(SNAI2) was recently identified [1]. The signature is present in publicly available datasets of all 
solid cancer types that we tried. These genes are coordinately expressed at various levels, but are 
significantly overexpressed only in samples that have exceeded a particular stage, specific to 
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each cancer type. A list of the top 64 genes of the signature is shown, for reference, in Table 1. 
We also found [2] that many of the genes of the signature, including α-SMA, are expressed by 
the cancer cells themselves in vivo, at least in one xenograft model of neuroblastoma that we 
tried [3], confirming that cancer cells have undergone a mesenchymal transition (the term EMT 
may not be accurate in this case, as the same signature is also present in cancers, such as 
neuroblastoma, that are not, strictly speaking, epithelial).  We refer to this multi-cancer signature 
as the “cancer mesenchymal transition signature.” It is characterized by a prominent presence of 
co-expressed genes COL11A1, THBS2, INHBA.  
 
Consistent with this hypothesis, the signature is not found present in either leukemia or normal 
tissues. We hypothesized, however, that a subset of these genes may still remain co-expressed 
with Slug even in nonsolid cancers. Such findings would shed light on the more general 
biological mechanism of Slug-based mesenchymal transition when it happens without the full 
myofibroblast-like transdifferentiation that occurs in invasive tumors (in which case the 
transformed cancer cells may be confused with stromal cancer associated fibroblasts). 
 
Results 
Here we report that further computational analysis in gene expression datasets of leukemia 
samples, as well as of normal human body multi-tissue datasets, revealed that a subset of the 
cancer mesenchymal transition signature, consisting at least of Slug, collagens COL1A1, 
COL1A2, COL3A1, COL6A3 and genes DCN and LUM remain strongly co-expressed in all 
cases. These results were reached by simply comparing the pairwise associations of the 64 genes 
of the full signature of Table 1 in various datasets. Furthermore, ranking the genes in terms of 
their association (such as mutual information) with SNAI2 in each data set consistently identifies 
the above seven genes close to the top of the list. 
 
To demonstrate the coexpression of the above seven genes, we generated corresponding heat 
maps including only these genes. 
 
The heat map of the TCGA leukemia dataset is shown in the Supplementary Figure available at 
www.ee.columbia.edu/~anastas/np/heatmap.leukemia.7genes.pdf  We observed that the same 
signature is also strongly associated in leukemia with the chemokine CXCL12 (aka SDF1), 
providing related biological insights. 
 
The heat map of the 504 normal samples from the “human body index” GSE7307 dataset is 
shown in the Supplementary Figure available at  
www.ee.columbia.edu/~anastas/np/heatmap.normal.7genes.pdf   
 
Remarkably, there is strong tissue specificity associated with the presence of the Slug-based 
EMT signature. At one end of the spectrum where (Table 2, left side), the signature appears 
absent in brain tissues. At the other end of the spectrum (Table 2, right side), the signature 
appears present in higher amounts in reproductive system tissues. This phenomenon is fully 
demonstrated in the color-coded table of all 504 samples that appears as Supplementary Table 
available at www.ee.columbia.edu/~anastas/np/snai2tissuetype.xlsx  
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Because EMT is known to generate cells with properties of stem cells [4], these results are 
compatible with the notion that, among normal human body tissues, the brain contains highly 
differentiated cells with the least amount of “stemness,” while the reproductive system contains 
cells with the highest amount of stemness. The lack of stemness in the normal state of brain cells 
is also consistent with our recent finding that the absence of the full Slug-based cancer 
mesenchymal transition signature in glioblastoma is associated with prolonged time to 
recurrence following treatment [5]. Glioblastoma samples reveal coexpression of most of the 
genes of Table 1, but COL11A1 is not as strongly coexpressed. 
We have also hypothesized [2, 3] that the full Slug-based cancer mesenchymal transition 
signature is triggered in solid cancers following contextual microenvironmental interactions 
when cancer cells encounter adipocytes. In that case, COL11A1 can serve as a reliable proxy of 
the full signature.  
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Table 1. Top genes coexpressed in the cancer mesenchymal transition signature. 
 
 
Rank Gene Rank Gene 
1 COL11A1 33 LOXL2 
2 THBS2 34 COL6A3 
3 COL10A1 35 MXRA5 
4 COL5A2 36 MFAP5 
5 INHBA 37 NUAK1 
6 LRRC15 38 RAB31 
7 COL5A1 39 TIMP3 
8 VCAN 40 CRISPLD2 
9 FAP 41 ITGBL1 
10 COL1A1 42 CDH11 
11 MMP11 43 TMEM158 
12 POSTN 44 SPOCK1 
13 COL1A2 45 SFRP4 
14 ADAM12 46 SERPINF1 
15 COL3A1 47 DCN 
16 LOX 48 C7orf10 
17 FN1 49 COPZ2 
18 AEBP1 50 NOX4 
19 SULF1 51 EDNRA 
20 FBN1 52 ACTA2 
21 ASPN 53 PDGFRB 
22 SPARC 54 RCN3 
23 CTSK 55 SNAI2 
24 TNFAIP6 56 C1QTNF3 
25 HNT 57 COMP 
26 EPYC 58 LGALS1 
27 MMP2 59 THY1 
28 PLAU 60 PCOLCE 
29 GREM1 61 COL6A2 
30 BGN 62 GLT8D2 
31 OLFML2B 63 NID2 
32 LUM 64 PRRX1 
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Table 2. Listing of the 20 samples at each extreme of the set of the 504 samples sorted in terms 
of Slug expression. At the left side of the Table the 20 samples with the minimum Slug 
expression are all brain tissues. At the right side of the Table, the 20 samples with the maximum 
Slug expression are all reproductive system tissues. 
 
 
 
Rank Sample Tissue SNAI2  Rank Sample Tissue SNAI2 
1 GSM175958 midbrain -2.39  475 GSM176134 vagina 8.87 
2 GSM176371 putamen -0.96  476 GSM176270 penis 8.94 
3 GSM176369 caudate -0.68  477 GSM176043 endometrium 9.00 
4 GSM176150 putamen -0.21  478 GSM176133 myometrium 9.02 
5 GSM175851 accumbens -0.20  479 GSM176145 myometrium 9.02 
6 GSM176394 substantia nigra_pars 
compacta 
0.16  480 GSM176131 ovary 9.05 
7 GSM176370 accumbens 0.17  481 GSM175833 cervix 9.13 
8 GSM176046 putamen 0.23  482 GSM176106 myometrium 9.15 
9 GSM176401 substantia nigra_pars 
compacta 
0.41  483 GSM176141 endometrium 9.19 
10 GSM175848 putamen 0.83  484 GSM176146 myometrium 9.21 
11 GSM176073 occipital_lobe 0.86  485 GSM175878 vagina 9.21 
12 GSM176454 thalamus_lateral nuclei 0.95  486 GSM176318 ovary 9.27 
13 GSM176364 accumbens 0.99  487 GSM176144 myometrium 9.41 
14 GSM176071 ventral_tegmental_area 1.00  488 GSM176254 myometrium 9.44 
15 GSM176061 thalamus 1.02  499 GSM176230 myometrium 9.46 
16 GSM176447 gloubus 
pallidum_external 
1.03  500 GSM176143 myometrium 9.61 
17 GSM176398 substantia 
nigra_reticulata 
1.08  501 GSM176135 cervix 9.85 
18 GSM176451 thalamus_subthalamic 
nucleus 
1.11  502 GSM176108 myometrium 9.86 
19 GSM176379 accumbens 1.20  503 GSM176320 myometrium 9.87 
20 GSM175959 midbrain 1.32  504 GSM176102 myometrium 11.25 
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